KEGG   DRUG: Heparin sodiumHelp
Entry
D02112                      Drug                                   

Name
Heparin sodium (JP17/USP/INN);
Parnaparin sodium (INN);
Liquemin sodium (TN)
Product
  Generic
HEPARIN SODIUM (Cardinal Health), HEPARIN SODIUM (Cardinal Health), HEPARIN SODIUM (Cardinal Health), HEPARIN SODIUM (Cardinal Health), HEPARIN SODIUM (Fresenius Kabi USA), HEPARIN SODIUM (General Injectables & Vaccines), HEPARIN SODIUM (General Injectables & Vaccines), HEPARIN SODIUM (Gland Pharma Limited), HEPARIN SODIUM (Hospira), HEPARIN SODIUM (Hospira), HEPARIN SODIUM (McKesson Packaging Services Business Unit of McKesson Corporation), HEPARIN SODIUM (McKesson Packaging Services Business Unit of McKesson Corporation), HEPARIN SODIUM (McKesson Packaging Services Business Unit of McKesson Corporation), HEPARIN SODIUM (Mylan Institutional LLC), HEPARIN SODIUM (Safecor Health), HEPARIN SODIUM (Sagent Pharmaceticals), HEPARIN SODIUM (Sagent Pharmaceuticals), HEPARIN SODIUM (Sagent Pharmaceuticals), HEPARIN SODIUM (Sagent Pharmaceuticals), HEPARIN SODIUM (Sandoz)
  Other
Class
Cardiovascular agent
 DG01709  Heparin anticoagulant
 DG01950  Antithrombotic agent
  DG01709  Heparin anticoagulant
Remark
Therapeutic category: 3334
ATC code: B01AB01 C05BA03 S01XA14
Chemical structure group: DG00150
Product (DG00150): D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03337<JP> D03353<JP/US>
Efficacy
Anticoagulant, Antithrombin III activator
  Disease
Disseminated intravascular coagulation [DS:H01587]
Target
SERPINC1 (AT3) [HSA:462] [KO:K03911]
  Pathway
hsa04610  Complement and coagulation cascades
Interaction
Drug interaction
Structure map
map07049  Antithrombosis agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B01 ANTITHROMBOTIC AGENTS
   B01A ANTITHROMBOTIC AGENTS
    B01AB Heparin group
     B01AB01 Heparin
      D02112  Heparin sodium (JP17/USP/INN) <JP/US>
 C CARDIOVASCULAR SYSTEM
  C05 VASOPROTECTIVES
   C05B ANTIVARICOSE THERAPY
    C05BA Heparins or heparinoids for topical use
     C05BA03 Heparin
      D02112  Heparin sodium (JP17/USP/INN) <JP/US>
 S SENSORY ORGANS
  S01 OPHTHALMOLOGICALS
   S01X OTHER OPHTHALMOLOGICALS
    S01XA Other ophthalmologicals
     S01XA14 Heparin
      D02112  Heparin sodium (JP17/USP/INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  33  Blood and body fluid agents
   333  Anticoagulants
    3334  Heparins
     D02112  Heparin sodium (JP17/USP/INN); Parnaparin sodium (INN)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for integumentary system
  55 Chilblain and chap remedies
   D02112  Heparin sodium (JP17/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
 Second-class OTC drugs
  Inorganic and organic chemicals
   Heparin sodium
    D02112  Heparin sodium (JP17/USP/INN)
Pharmaceutical additives in Japan [BR:br08316]
 Stabilizing agent
  D02112  [001570] Heparin sodium
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Immune system
   Complement and coagulation
    SERPINC1 (AT3)
     D02112  Heparin sodium (JP17/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D02112  Heparin sodium
  D02112  Heparin sodium injection
BRITE hierarchy
Other DBs
CAS: 9041-08-1
PubChem: 7849173
NIKKAJI: J209.198D
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system